Article
ICL suits low to high myopia, according to 3-year results
San Diego-The Implantable Collamer Lens (ICL, STAAR Surgical) appears to be safe and effective for treating low to high myopia based on the 3-year FDA study results. There is, however, a low risk of developing a cataract as a result of implantation, explained Harry Grabow, MD, who reported the findings at the annual meeting of the American Society of Cataract and Refractive Surgery.The criteria for inclusion in the myopic ICL study were –3 to –20 D of spherical equivalent (mean preoperative refraction, –10 D) and up to 2.5 D of cylinder. The refractive results were good with a mean stable postoperative refraction of about –0.5 D.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
